Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

Patients with the MELAS syndrome experience devastating mental impairment. This study will evaluate the effectiveness of the drug dichloroacetate (DCA) to reduce the symptoms of MELAS.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 June 2005.

1 Mar 2000 10 Sep 2003 Unavailable Unavailable 1 Sep 2004 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Crossover Assignment

Contacts

Not available